Evidence map›Paper›PMID 37713441›Full record

ArticlePloS one2023

Geospatial availability of breast cancer treatment modalities and hypothetical access improvement in Ghana: A nationwide survey.

Sarah Schoenhals, Meghan E Mali, Edward K Sutherland, Justin Sorenson, Florence Dedey, Jonathan Nellermoe, Angel Flores-Huidobro Martinez, Mamadou D Tounkara, Raymond R Price, Kirstyn E Brownson

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarah SchoenhalsCenter for Global Surgery, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.ORCID 0000-0002-8484-7465
Meghan E MaliCenter for Global Surgery, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.ORCID 0000-0001-6674-9880
Edward K SutherlandCenter for Global Surgery, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.ORCID 0000-0001-9304-1706
Justin SorensonJ.Willard Marriot Library, University of Utah, Salt Lake City, Utah, United States of America.
Florence DedeyDepartment of Surgery, University of Ghana Medical School, Accra, Greater Accra, Ghana.
Jonathan NellermoeCenter for Global Surgery, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
Angel Flores-Huidobro MartinezCenter for Global Surgery, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
Mamadou D TounkaraCenter for Global Surgery, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
Raymond R PriceCenter for Global Surgery, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
Kirstyn E BrownsonCenter for Global Surgery, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer in Ghana is a growing public health problem with increasing incidence and poor outcomes. Lack of access to comprehensive treatment in Ghana may be a contributing factor to its high mortality. The purpose of this study was to evaluate the availability of treatments nationwide and systematically identify high yield areas for targeted expansion. We conducted a cross-sectional, nationwide hospital-based survey from November 2020-October 2021. Surveys were conducted in person with trained research assistants and described hospital availability of all breast cancer treatments and personnel. All individual treatment services were reported, and hospitals were further stratified into levels of multi-modal treatment modeled after the National Comprehensive Cancer Network (NCCN) Framework treatment recommendations for low-resource settings. Level 3 included Tamoxifen and surgery (mastectomy with axillary lymph node sampling); Level 2 included Level 3 plus radiation, aromatase inhibitors, lumpectomy, and sentinel lymph node biopsy; Level 1 included Level 2 plus Her2 therapy and breast reconstruction. Hospitals were identified that could expand to these service levels based on existing services, location and personnel. The distance of the total population from treatment services before and after hypothetical expansion was determined with a geospatial analysis. Of the 328 participating hospitals (95% response rate), 9 hospitals had Level 3 care, 0 had Level 2, and 2 had Level 1. Twelve hospitals could expand to Level 3, 1 could expand to Level 2, and 1 could expand to Level 1. With expansion, the population percentage within 75km of Level 1, 2 and 3 care would increase from 42% to 50%, 0 to 6% and 44% to 67%, respectively. Multi-modal breast cancer treatment is available in Ghana, but it is not accessible to most of the population. Leveraging the knowledge of current resources and population proximity provides an opportunity to identify high-yield areas for targeted expansion.

Indexed as

Breast NeoplasmsCross-Sectional StudiesFemaleGhanaHumansMastectomyOncogenes

Identifiers

PMID37713441
PMCPMC10503733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.